Chen et al26 discovered that the CCL20-CCR6 axis is responsible for the movement of circulating Tregs into the TME, consequently contributing to disease progression and unfavorable outcomes in HCC patients. This evidence concerns the gene CCL20 and hepatocellular carcinoma.